QR kód

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients

Abstract Background In the past, multiple sclerosis (MS) medications have been primarily designed to modulate T cell properties. Based on the emerging concept that B cells are equally important for the propagation of MS, we compared the effect of four commonly used, primarily T cell-targeting MS med...

Celý popis

Uloženo v:
Hlavní autoři: Jan W. Traub, Hannah L. Pellkofer, Katja Grondey, Ira Seeger, Christoph Rowold, Wolfgang Brück, Leila Husseini, Silke Häusser-Kinzel, Martin S. Weber
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2019-11-01
Edice:Journal of Neuroinflammation
Témata:
Multiple sclerosis
Natalizumab
B cells
Dimethyl fumarate
Glatiramer acetate
Fingolimod
On-line přístup:http://link.springer.com/article/10.1186/s12974-019-1593-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky